Targeting efficacy of spironolactone in patients with heart failure with preserved ejection fraction: the TOPCAT study - Zhou - ESC Heart Failure - Wiley Online Library
Detection and Management of Geographic Disparities in the TOPCAT Trial: Lessons Learned and Derivative Recommendations | JACC: Basic to Translational Science
Under-Enrollment of Obese Heart Failure with Preserved Ejection Fraction Patients in Major HFpEF Clinical Trials - Journal of Cardiac Failure
Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Protocols
Detection and Management of Geographic Disparities in the TOPCAT Trial: Lessons Learned and Derivative Recommendations - ScienceDirect
Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial | Circulation
Spectrum of epidemiological and clinical findings in patients with heart failure with preserved ejection fraction stratified by study design: a systematic review - Vaduganathan - 2016 - European Journal of Heart Failure - Wiley Online Library
Rates of Spironolactone Initiation and Subsequent Hyperkalemia Hospitalizations in Patients with Heart Failure with Preserved Ejection Fraction Following the TOPCAT trial: A Cohort Study of Medicare Beneficiaries - Journal of Cardiac Failure
Towards precision medicine in heart failure | Nature Reviews Cardiology
Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Manual of Operations
Abstract 14199: Defining Phenotypic Representativeness of the TOPCAT Trial to a Real-World Electronic Health Record Using Multidimensional Phenomaps | Circulation
Prognostic Importance of Temporal Changes in Resting Heart Rate in Heart Failure and Preserved Ejection Fraction: From the TOPCAT Study | JACC: Heart Failure
PDF) C2HEST score predicts clinical outcomes in heart failure with preserved ejection fraction: a secondary analysis of the TOPCAT trial
Detection and Management of Geographic Disparities in the TOPCAT Trial: Lessons Learned and Derivative Recommendations - ScienceDirect
Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: The TOPCAT Trial - ScienceDirect
Assessing the Eligibility Criteria in Phase III Randomized Controlled Trials of Drug Therapy in Heart Failure With Preserved Ejection Fraction: The Critical Play-Off Between a “Pure” Patient Phenotype and the Generalizability of
Clinical information from repeated blood pressure measurements in the management of heart failure with preserved ejection fraction | Hypertension Research
Data-driven identification of heart failure disease states and progression pathways using electronic health records | Scientific Reports
Spironolactone Metabolites in TOPCAT — New Insights into Regional Variation | NEJM
CardsJC: PARAGON-HF Trial Journal Club - Cardionerds
Spironolactone for Heart Failure with Preserved Ejection Fraction | NEJM
